Coya Therapeutics, Inc. Common Stock (COYA) Stock Analysis

Coya Therapeutics, Inc. Common Stock (COYA) is a publicly traded company in the HEALTHCARE sector. It trades at $4.73, carries a market capitalization of $115.17M. This page summarizes the public market data, fundamentals, and frequently asked questions for COYA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Coya Therapeutics, Inc. Common Stock currently has a Bullish sentiment score of 0.63.

About Coya Therapeutics, Inc. Common Stock

Coya Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Houston, Texas, dedicated to developing innovative therapies that enhance the effectiveness of regulatory T cells (Tregs) for the treatment of autoimmune and neurodegenerative diseases. With a proprietary platform, Coya is advancing its pipeline towards critical indications such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis, positioning itself as a leader in Treg modulation. As the company progresses ...

GNG Research Analysis

GNG Research scores Coya Therapeutics, Inc. Common Stock (COYA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for COYA.

Frequently Asked Questions

Does COYA pay dividends?

Coya Therapeutics, Inc. Common Stock (COYA) does not currently pay a regular dividend.

What is COYA's market cap?

Coya Therapeutics, Inc. Common Stock (COYA) has a market capitalization of $115.17M with a current stock price of $4.73.